 | • レポートコード：MRC2012B0249 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、細胞診・HPV検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。細胞診・HPV検査の種類別市場規模（システム、アッセイキット、サービス）、用途別市場規模（病院、クリニック、研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott、OncoHealth、Cepheid、Arbor Vita、Hologic、Becton Dickinson、Fujirebio、Roche、QIAGEN、 ・地域別グローバル市場分析 2015年-2020年 ・細胞診・HPV検査の北米市場（アメリカ、カナダ、メキシコ） ・細胞診・HPV検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・細胞診・HPV検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・細胞診・HPV検査の南米市場（ブラジル、アルゼンチン） ・細胞診・HPV検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：システム、アッセイキット、サービス ・用途別分析：病院、クリニック、研究所 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Cytology and HPV Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.6% in the forecast period of 2020 to 2025 and will expected to reach USD 8285 million by 2025, from USD 7783.4 million in 2019.
The Cytology and HPV Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cytology and HPV Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cytology and HPV Testing market has been segmented into:
Systems
Assay Kits
Services
By Application, Cytology and HPV Testing has been segmented into:
Hospitals
Clinics
Research Institutes
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cytology and HPV Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Cytology and HPV Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cytology and HPV Testing market.
The report offers in-depth assessment of the growth and other aspects of the Cytology and HPV Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cytology and HPV Testing Market Share Analysis
Cytology and HPV Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cytology and HPV Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cytology and HPV Testing sales, revenue and market share for each player covered in this report.
The major players covered in Cytology and HPV Testing are:
Abbott
OncoHealth
Cepheid
Arbor Vita
Hologic
Becton Dickinson
Fujirebio
Roche
QIAGEN
Table of Contents
1 Cytology and HPV Testing Market Overview
1.1 Product Overview and Scope of Cytology and HPV Testing
1.2 Classification of Cytology and HPV Testing by Type
1.2.1 Global Cytology and HPV Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cytology and HPV Testing Revenue Market Share by Type in 2019
1.2.3 Systems
1.2.4 Assay Kits
1.2.5 Services
1.3 Global Cytology and HPV Testing Market by Application
1.3.1 Overview: Global Cytology and HPV Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.4 Global Cytology and HPV Testing Market by Regions
1.4.1 Global Cytology and HPV Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cytology and HPV Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cytology and HPV Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cytology and HPV Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cytology and HPV Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cytology and HPV Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cytology and HPV Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 OncoHealth
2.2.1 OncoHealth Details
2.2.2 OncoHealth Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 OncoHealth SWOT Analysis
2.2.4 OncoHealth Product and Services
2.2.5 OncoHealth Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cepheid
2.3.1 Cepheid Details
2.3.2 Cepheid Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cepheid SWOT Analysis
2.3.4 Cepheid Product and Services
2.3.5 Cepheid Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Arbor Vita
2.4.1 Arbor Vita Details
2.4.2 Arbor Vita Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Arbor Vita SWOT Analysis
2.4.4 Arbor Vita Product and Services
2.4.5 Arbor Vita Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hologic
2.5.1 Hologic Details
2.5.2 Hologic Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hologic SWOT Analysis
2.5.4 Hologic Product and Services
2.5.5 Hologic Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Becton Dickinson
2.6.1 Becton Dickinson Details
2.6.2 Becton Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Becton Dickinson SWOT Analysis
2.6.4 Becton Dickinson Product and Services
2.6.5 Becton Dickinson Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Fujirebio
2.7.1 Fujirebio Details
2.7.2 Fujirebio Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Fujirebio SWOT Analysis
2.7.4 Fujirebio Product and Services
2.7.5 Fujirebio Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Roche SWOT Analysis
2.8.4 Roche Product and Services
2.8.5 Roche Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 QIAGEN
2.9.1 QIAGEN Details
2.9.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 QIAGEN SWOT Analysis
2.9.4 QIAGEN Product and Services
2.9.5 QIAGEN Cytology and HPV Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cytology and HPV Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cytology and HPV Testing Players Market Share
3.2.2 Top 10 Cytology and HPV Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cytology and HPV Testing Revenue and Market Share by Regions
4.2 North America Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
4.5 South America Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
5 North America Cytology and HPV Testing Revenue by Countries
5.1 North America Cytology and HPV Testing Revenue by Countries (2015-2020)
5.2 USA Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
6 Europe Cytology and HPV Testing Revenue by Countries
6.1 Europe Cytology and HPV Testing Revenue by Countries (2015-2020)
6.2 Germany Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
6.3 UK Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
6.4 France Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cytology and HPV Testing Revenue by Countries
7.1 Asia-Pacific Cytology and HPV Testing Revenue by Countries (2015-2020)
7.2 China Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
7.5 India Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
8 South America Cytology and HPV Testing Revenue by Countries
8.1 South America Cytology and HPV Testing Revenue by Countries (2015-2020)
8.2 Brazil Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cytology and HPV Testing by Countries
9.1 Middle East & Africa Cytology and HPV Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cytology and HPV Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Cytology and HPV Testing Market Forecast by Type (2019-2024)
10.3 Systems Revenue Growth Rate (2015-2025)
10.4 Assay Kits Revenue Growth Rate (2015-2025)
10.5 Services Revenue Growth Rate (2015-2025)
11 Global Cytology and HPV Testing Market Segment by Application
11.1 Global Cytology and HPV Testing Revenue Market Share by Application (2015-2020)
11.2 Cytology and HPV Testing Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Research Institutes Revenue Growth (2015-2020)
12 Global Cytology and HPV Testing Market Size Forecast (2021-2025)
12.1 Global Cytology and HPV Testing Market Size Forecast (2021-2025)
12.2 Global Cytology and HPV Testing Market Forecast by Regions (2021-2025)
12.3 North America Cytology and HPV Testing Revenue Market Forecast (2021-2025)
12.4 Europe Cytology and HPV Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cytology and HPV Testing Revenue Market Forecast (2021-2025)
12.6 South America Cytology and HPV Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cytology and HPV Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cytology and HPV Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cytology and HPV Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cytology and HPV Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cytology and HPV Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Corporate Information, Location and Competitors
Table 6. Abbott Cytology and HPV Testing Major Business
Table 7. Abbott Cytology and HPV Testing Total Revenue (USD Million) (2017-2018)
Table 8. Abbott SWOT Analysis
Table 9. Abbott Cytology and HPV Testing Product and Solutions
Table 10. Abbott Cytology and HPV Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. OncoHealth Corporate Information, Location and Competitors
Table 12. OncoHealth Cytology and HPV Testing Major Business
Table 13. OncoHealth Cytology and HPV Testing Total Revenue (USD Million) (2018-2019)
Table 14. OncoHealth SWOT Analysis
Table 15. OncoHealth Cytology and HPV Testing Product and Solutions
Table 16. OncoHealth Cytology and HPV Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Cepheid Corporate Information, Location and Competitors
Table 18. Cepheid Cytology and HPV Testing Major Business
Table 19. Cepheid Cytology and HPV Testing Total Revenue (USD Million) (2017-2018)
Table 20. Cepheid SWOT Analysis
Table 21. Cepheid Cytology and HPV Testing Product and Solutions
Table 22. Cepheid Cytology and HPV Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Arbor Vita Corporate Information, Location and Competitors
Table 24. Arbor Vita Cytology and HPV Testing Major Business
Table 25. Arbor Vita Cytology and HPV Testing Total Revenue (USD Million) (2017-2018)
Table 26. Arbor Vita SWOT Analysis
Table 27. Arbor Vita Cytology and HPV Testing Product and Solutions
Table 28. Arbor Vita Cytology and HPV Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Hologic Corporate Information, Location and Competitors
Table 30. Hologic Cytology and HPV Testing Major Business
Table 31. Hologic Cytology and HPV Testing Total Revenue (USD Million) (2017-2018)
Table 32. Hologic SWOT Analysis
Table 33. Hologic Cytology and HPV Testing Product and Solutions
Table 34. Hologic Cytology and HPV Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Becton Dickinson Corporate Information, Location and Competitors
Table 36. Becton Dickinson Cytology and HPV Testing Major Business
Table 37. Becton Dickinson Cytology and HPV Testing Total Revenue (USD Million) (2017-2018)
Table 38. Becton Dickinson SWOT Analysis
Table 39. Becton Dickinson Cytology and HPV Testing Product and Solutions
Table 40. Becton Dickinson Cytology and HPV Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Fujirebio Corporate Information, Location and Competitors
Table 42. Fujirebio Cytology and HPV Testing Major Business
Table 43. Fujirebio Cytology and HPV Testing Total Revenue (USD Million) (2017-2018)
Table 44. Fujirebio SWOT Analysis
Table 45. Fujirebio Cytology and HPV Testing Product and Solutions
Table 46. Fujirebio Cytology and HPV Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Roche Corporate Information, Location and Competitors
Table 48. Roche Cytology and HPV Testing Major Business
Table 49. Roche Cytology and HPV Testing Total Revenue (USD Million) (2017-2018)
Table 50. Roche SWOT Analysis
Table 51. Roche Cytology and HPV Testing Product and Solutions
Table 52. Roche Cytology and HPV Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. QIAGEN Corporate Information, Location and Competitors
Table 54. QIAGEN Cytology and HPV Testing Major Business
Table 55. QIAGEN Cytology and HPV Testing Total Revenue (USD Million) (2017-2018)
Table 56. QIAGEN SWOT Analysis
Table 57. QIAGEN Cytology and HPV Testing Product and Solutions
Table 58. QIAGEN Cytology and HPV Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Cytology and HPV Testing Revenue (Million USD) by Players (2015-2020)
Table 60. Global Cytology and HPV Testing Revenue Share by Players (2015-2020)
Table 61. Global Cytology and HPV Testing Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Cytology and HPV Testing Revenue Market Share by Regions (2015-2020)
Table 63. North America Cytology and HPV Testing Revenue by Countries (2015-2020)
Table 64. North America Cytology and HPV Testing Revenue Market Share by Countries (2015-2020)
Table 65. Europe Cytology and HPV Testing Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Cytology and HPV Testing Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Cytology and HPV Testing Revenue by Countries (2015-2020)
Table 68. South America Cytology and HPV Testing Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Cytology and HPV Testing Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Cytology and HPV Testing Revenue Market Share by Countries (2015-2020)
Table 71. Global Cytology and HPV Testing Revenue (Million USD) by Type (2015-2020)
Table 72. Global Cytology and HPV Testing Revenue Share by Type (2015-2020)
Table 73. Global Cytology and HPV Testing Revenue Forecast by Type (2021-2025)
Table 74. Global Cytology and HPV Testing Revenue by Application (2015-2020)
Table 75. Global Cytology and HPV Testing Revenue Share by Application (2015-2020)
Table 76. Global Cytology and HPV Testing Revenue Forecast by Application (2021-2025)
Table 77. Global Cytology and HPV Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cytology and HPV Testing Picture
Figure 2. Global Cytology and HPV Testing Revenue Market Share by Type in 2019
Figure 3. Systems Picture
Figure 4. Assay Kits Picture
Figure 5. Services Picture
Figure 6. Cytology and HPV Testing Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Research Institutes Picture
Figure 10. Global Cytology and HPV Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Cytology and HPV Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Cytology and HPV Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Cytology and HPV Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Cytology and HPV Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Cytology and HPV Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Cytology and HPV Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Cytology and HPV Testing Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Cytology and HPV Testing Revenue Market Share in 2019
Figure 19. Global Top 10 Players Cytology and HPV Testing Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Cytology and HPV Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Cytology and HPV Testing Revenue Market Share by Regions (2015-2020)
Figure 23. Global Cytology and HPV Testing Revenue Market Share by Regions in 2018
Figure 24. North America Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 25. Europe Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 27. South America Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 29. North America Cytology and HPV Testing Revenue Market Share by Countries (2015-2020)
Figure 30. North America Cytology and HPV Testing Revenue Market Share by Countries in 2019
Figure 31. USA Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 32. Canada Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 34. Europe Cytology and HPV Testing Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Cytology and HPV Testing Revenue Market Share by Countries in 2019
Figure 36. Germany Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 37. UK Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 38. France Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 39. Russia Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 40. Italy Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Cytology and HPV Testing Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Cytology and HPV Testing Revenue Market Share by Countries in 2019
Figure 43. China Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 44. Japan Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 45. Korea Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 46. India Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 48. South America Cytology and HPV Testing Revenue Market Share by Countries (2015-2020)
Figure 49. South America Cytology and HPV Testing Revenue Market Share by Countries in 2019
Figure 50. Brazil Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Cytology and HPV Testing Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Cytology and HPV Testing Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 55. UAE Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Cytology and HPV Testing Revenue and Growth Rate (2015-2020)
Figure 58. Global Cytology and HPV Testing Revenue Share by Type (2015-2020)
Figure 59. Global Cytology and HPV Testing Revenue Share by Type in 2019
Figure 60. Global Cytology and HPV Testing Market Share Forecast by Type (2021-2025)
Figure 61. Global Systems Revenue Growth Rate (2015-2020)
Figure 62. Global Assay Kits Revenue Growth Rate (2015-2020)
Figure 63. Global Services Revenue Growth Rate (2015-2020)
Figure 64. Global Cytology and HPV Testing Revenue Share by Application (2015-2020)
Figure 65. Global Cytology and HPV Testing Revenue Share by Application in 2019
Figure 66. Global Cytology and HPV Testing Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Research Institutes Revenue Growth Rate (2015-2020)
Figure 70. Global Cytology and HPV Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Cytology and HPV Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Cytology and HPV Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Cytology and HPV Testing Revenue Market Forecast (2021-2025)
Figure 74. Europe Cytology and HPV Testing Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Cytology and HPV Testing Revenue Market Forecast (2021-2025)
Figure 76. South America Cytology and HPV Testing Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Cytology and HPV Testing Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
酵素免疫測定法（ELISA）検査の世界市場（～2026年） Enzyme-linked immunosorbent assay (ELISA) is mainly used to measure antibodies, antigens, proteins, and glycoproteins in biological samples. Hospitals and diagnostic centers were the major end-users to the ELISA test market. The demand ELISA testing in this end-user segment is mainly due to factors …- 豚診断検査の世界市場（～2026年） Swine diagnostic testing is extremely important for pork breeders to keep adverse effects on production and minimum economic losses. Growing consumption of pork meat is expected to be the prime factor driving the growth of global swine diagnostic testing market. Market Analysis and Insights: Global …
- 血液検査の世界市場（～2026年） A blood test is the analysis of blood sample performed in a laboratory and the blood is usually taken from the vein in the arm through a needle, or through a finger prick to determine patient’s health status. Blood tests are very often used in health care to understand biochemical and physiological …
- 膣炎迅速検査の世界市場（～2026年） Vaginosis is a defined as the changing conditions of the vagina. Bacterial vaginosis is an abnormal overgrowth of normal bacteria in the vagina and causes vaginal smelly discharge. The increasing prevalence of most common vaginal and sexually transmitted infection worldwide is expected to propel the…
- 梅毒検査の世界市場（～2026年） Syphilis is one of the vital sexually transmitted infections (STIs) caused by the bacteria named, Treponema pallidum, and can lead to long-term complications, if not diagnosed adequately. The latest trend gaining momentum in the market is increase in premarital screening. Premarital screening is a h…